These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8516290)

  • 21. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.
    Joslin JM; Fernald AA; Tennant TR; Davis EM; Kogan SC; Anastasi J; Crispino JD; Le Beau MM
    Blood; 2007 Jul; 110(2):719-26. PubMed ID: 17420284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.
    Dubourg C; Toutain B; Hélias C; Henry C; Lessard M; Le Gall JY; Le Treut A; Guenet L
    Cancer Genet Cytogenet; 2002 Apr; 134(1):33-7. PubMed ID: 11996793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
    Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
    Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
    Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S; Rödjer S; Swolin B
    Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality.
    Sankar M; Tanaka K; Kumaravel TS; Arif M; Shintani T; Yagi S; Kyo T; Dohy H; Kamada N
    Leukemia; 1998 Apr; 12(4):510-6. PubMed ID: 9557609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Deletion of the long arm of chromosome 5 in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Michalová K
    Cas Lek Cesk; 2001 Feb; 140(2):43-6. PubMed ID: 11262906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.
    Nagarajan L; Zavadil J; Claxton D; Lu X; Fairman J; Warrington JA; Wasmuth JJ; Chinault AC; Sever CE; Slovak ML
    Blood; 1994 Jan; 83(1):199-208. PubMed ID: 8274735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML.
    Pedersen B
    Leukemia; 1996 Dec; 10(12):1883-90. PubMed ID: 8946926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
    Lezon-Geyda K; Najfeld V; Johnson EM
    Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
    Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
    Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
    Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS
    Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Order of human hematopoietic growth factor and receptor genes on the long arm of chromosome 5, as determined by fluorescence in situ hybridization.
    Kluck PM; Wiegant J; Raap AK; Vrolijk H; Tanke HJ; Willemze R; Landegent JE
    Ann Hematol; 1993 Jan; 66(1):15-20. PubMed ID: 8431518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
    Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
    Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases.
    Guenet L; Henry C; Toutain B; Dubourg C; Le Gall JY; David V; Le Treut A
    Cytogenet Cell Genet; 2000; 88(1-2):82-6. PubMed ID: 10773672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical mapping of the minimal region of loss in 5q- chromosome.
    Fairman J; Chumakov I; Chinault AC; Nowell PC; Nagarajan L
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7406-10. PubMed ID: 7638206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.